Visit CONTRACT PHARMA at Booth 1163

Interphex: MilliporeSigma Talks Formulation Trends

05.02.18

Jeffrey Shumway shares insights as MilliporeSigma's Associate Director of Business Development, Formulation & Drug Delivery



At Interphex 2018, Associate Director of Business Development - Formulation & Drug Delivery at MilliporeSigma, Jeff Shumway, talks formulation industry trends that have led to market needs being met, including evolution and change of their business partners' pipelines. This includes business partners' needs for an available system to enable easier access to information. Shumway says we are also seeing a shift in the biologics space towards continuous manufacturing and next generation processes, which means that the formulation process is changing on their end.